Sign In

Login

Password

Forgot Password ? Sign Up

Ketamin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ketamin" in German language version.

refsWebsite
Global rank German rank
37nih.gov
4th place
7th place
33doi.org
2nd place
3rd place
4drugbank.ca
4,294th place
2,006th place
4clinicaltrials.gov
5,225th place
2,461st place
4europa.eu
68th place
29th place
2chemspider.com
8,573rd place
1,211th place
2wikidata.org
43rd place
985th place
2fda.gov
447th place
751st place
1sigmaaldrich.com
924th place
87th place
1who.int
195th place
255th place
1espacenet.com
800th place
160th place
1cas.org
8,332nd place
1,213th place
1pfizermed.de
low place
low place
1deutsche-apotheker-zeitung.de
low place
797th place
1welt.de
201st place
11th place
1bloomberg.com
99th place
323rd place
1gov.uk
432nd place
770th place
1tumblr.com
784th place
1,295th place
1feralhouse.com
low place
low place
1frontiersin.org
4,679th place
1,728th place
1web.archive.org
1st place
1st place
1bgbl.de
2,628th place
166th place
1bbc.co.uk
8th place
37th place
1telegraph.co.uk
30th place
92nd place

bbc.co.uk

news.bbc.co.uk

bgbl.de

bloomberg.com

cas.org

commonchemistry.cas.org

chemspider.com

clinicaltrials.gov

deutsche-apotheker-zeitung.de

doi.org

  • Sass W, Fusari S: Analytical Profiles of Drug Substances. Band 6. Academic Press, 1977, ISBN 978-0-12-260806-3, Ketamine, S. 297–322, doi:10.1016/S0099-5428(08)60347-0.
  • B. Sinner, B. M. Graf: Ketamine. In: Handbook of experimental pharmacology. Nummer 182, 2008, S. 313–333, doi:10.1007/978-3-540-74806-9_15, PMID 18175098 (Review).
  • SC Turfus, MC Parkin, DA Cowan, JM Halket, NW Smith, RA Braithwaite, SP Elliot, GB Steventon, AT Kicman: Use of human microsomes and deuterated substrates: an alternative approach for the identification of novel metabolites of ketamine by mass spectrometry. In: Drug Metab Dispos. Band 37, Nr. 8, 2009, S. 1769–78, doi:10.1124/dmd.108.026328, PMID 19448136, PMC 2712439 (freier Volltext) – (englisch).
  • E Kumlien, P Hartvig, S Valind, I Oye, J Tedroff, B Långström: NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. In: Epilepsia. Band 40, Nr. 1, 1999, S. 30–7, doi:10.1111/j.1528-1157.1999.tb01985.x, PMID 9924899 (englisch).
  • L Chen, Y Gong, R Salter: Synthesis of carbon-14 labeled ketamine and norketamine. In: J Labelled Comp Radiopharm. Band 61, Nr. 11, 2018, S. 864–868, doi:10.1002/jlcr.3669, PMID 29992626 (englisch).
  • L. V. Sayson, C. J. Botanas, R. J. P. Custodio et al.: The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors. In: Psychopharmacology (Berl). Band 236, Nr. 7, 2019, S. 2201–2210, doi:10.1007/s00213-019-05219-x, PMID 30891619 (englisch).
  • M. H. Y. Tang, T. C. Li, C. K. Lai, Y. K. Chong, C. K. Ching, T. W. L. Mak: Emergence of new psychoactive substance 2-fluorodeschloroketamine: Toxicology and urinary analysis in a cluster of patients exposed to ketamine and multiple analogues. In: Forensic Sci Int. Band 312, 2020, S. 110327, doi:10.1016/j.forsciint.2020.110327, PMID 32460225 (englisch).
  • W Hevers, SH Hadley, H Lüddens, J Amin: Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits. In: J. Neurosci. Band 28, Nr. 20, 2008, S. 5383–5393, doi:10.1523/JNEUROSCI.5443-07.2008, PMID 18480294 (englisch).
  • SE Strasburger, PM Bhimani, JH Kaabe u. a.: What is the mechanism of Ketamine’s rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. In: J Clin Pharm Ther. Band 42, Nr. 2, 2017, S. 147–154, doi:10.1111/jcpt.12497, PMID 28111761 (englisch).
  • Y Yang, Y Cui, K Sang, Y Dong, Z Ni, S Ma, H Hu: Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. In: Nature. Band 554, Nr. 7692, 2018, S. 317–322, doi:10.1038/nature25509, PMID 29446381 (englisch).
  • Artigas F, Celada P, Bortolozzi A: Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies. In: Eur Neuropsychopharmacol. Band 28, Nr. 4, April 2018, S. 457–482, doi:10.1016/j.euroneuro.2018.01.005, PMID 29525411 (englisch).
  • YQ Wan, JG Feng, M Li, MZ Wang, L Liu, X Liu, XX Duan, CX Zhang, XB Wang: Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats. In: Exp. Mol. Med. Band 50, Nr. 10, 2018, S. 140, doi:10.1038/s12276-018-0164-4, PMID 30369596, PMC 6204429 (freier Volltext) – (englisch).
  • S Chaki, JI Yamaguchi: Now is the time for (2R,6R)-hydroxynorketamine to be viewed independently from its parent drug. In: Pharmacol. Biochem. Behav. Band 175, 2018, S. 24–26, doi:10.1016/j.pbb.2018.09.005, PMID 30201385 (englisch).
  • JN Highland, PJ Morris, P Zanos u. a.: Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of ( 2R,6R)-hydroxynorketamine. In: J. Psychopharmacol. (Oxford). 2018, S. 269881118812095, doi:10.1177/0269881118812095, PMID 30488740 (englisch).
  • H.A. Adams, C. Werner: Vom Racemat zum Eutomer: (S)-Ketamin – Renaissance einer Substanz? In: Anaesthesist, Band 46, 1997, S. 1026–1042. PMID 9451486, doi:10.1007/s001010050503
  • G. Hempelmann, D. F. M. Kuhn: Klinischer Stellenwert des S-(+)-Ketamin. In: Der Anaesthesist, Band 46, 1997, S. S3–S7, doi:10.1007/PL00002461.
  • KR Jat, D Chawla: Ketamine for management of acute exacerbations of asthma in children. In: Cochrane Database Syst Rev. Band 11, 2012, S. CD009293, doi:10.1002/14651858.CD009293.pub2, PMID 23152273 (englisch).
  • N. Diazgranados, L. Ibrahim, N. E. Brutsche, A. Newberg, P. Kronstein, S. Khalife, W. A. Kammerer, Z. Quezado, D. A. Luckenbaugh, G. Salvadore, R. Machado-Vieira, H. K. Manji, C. A. Zarate: A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. In: Archives of General Psychiatry. Band 67, Nummer 8, August 2010, S. 793–802, doi:10.1001/archgenpsychiatry.2010.90. PMID 20679587. PMC 3000408 (freier Volltext).
  • D. R. Lara, L. W. Bisol, L. R. Munari: Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression. In: The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum. Band 16, Nummer 9, Oktober 2013, S. 2111–2117, doi:10.1017/S1461145713000485, PMID 23683309.
  • A. C. Nugent, N. Diazgranados, P. J. Carlson, L. Ibrahim, D. A. Luckenbaugh, N. Brutsche, P. Herscovitch, W. C. Drevets, C. A. Zarate: Neural correlates of rapid antidepressant response to ketamine in bipolar disorder. In: Bipolar disorders. Band 16, Nummer 2, März 2014, S. 119–128, doi:10.1111/bdi.12118, PMID 24103187, PMC 3949142 (freier Volltext).
  • A. McGirr, M. T. Berlim, D. J. Bond, M. P. Fleck, L. N. Yatham, R. W. Lam: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. In: Psychological medicine. Band 45, Nummer 4, März 2015, S. 693–704, doi:10.1017/S0033291714001603, PMID 25010396 (Review).
  • C. M. Coyle, K. R. Laws: The use of ketamine as an antidepressant: a systematic review and meta-analysis. In: Human psychopharmacology. Band 30, Nummer 3, Mai 2015, S. 152–163, doi:10.1002/hup.2475, PMID 25847818 (Review).
  • L. Reinstatler, N. A. Youssef: Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature. In: Drugs in R&D. Band 15, Nummer 1, März 2015, S. 37–43, doi:10.1007/s40268-015-0081-0, PMID 25773961, PMC 4359177 (freier Volltext) (Review).
  • M. C. Gregers, S. Mikkelsen, K. P. Lindvig, A. C. Brøchner: Ketamine as an Anesthetic for Patients with Acute Brain Injury: A Systematic Review. In: Neurocritical care. Band 33, Nummer 1, 08 2020, S. 273–282, doi:10.1007/s12028-020-00975-7, PMID 32328972, PMC 7223585 (freier Volltext).
  • M. Schönenberg, U. Reichwald, G. Domes, A. Badke, M. Hautzinger: Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims. In: Psychopharmacology. Band 182, Nummer 3, November 2005, S. 420–425, doi:10.1007/s00213-005-0094-4, PMID 16012867.
  • Zhaochen Luo, Dayong Tian, Ming Zhou, Wenjie Xiao, Yachun Zhang, Mingming Li, Baokun Sui, Wei Wang, Huashi Guan, Huanchun Chen, Zhen F. Fu, Ling Zhao, Matthias Johannes Schnell: λ-Carrageenan P32 Is a Potent Inhibitor of Rabies Virus Infection. In: PLOS ONE. 10, 2015, S. e0140586, doi:10.1371/journal.pone.0140586.
  • K. L. Jansen, R. Darracot-Cankovic: The nonmedical use of ketamine, part two: A review of problem use and dependence. In: Journal of psychoactive drugs. Band 33, Nummer 2, 2001 Apr-Jun, S. 151–158, doi:10.1080/02791072.2001.10400480, PMID 11476262 (Review).
  • Jessica A. Albright, Sarah A. Stevens, Douglas J. Beussman: Detecting ketamine in beverage residues: Application in date rape detection. In: Drug Testing and Analysis. Vol. 4, No. 5, Mai 2012, S. 337–341, doi:10.1002/dta.335. PMID 22114065.
  • M. C. Grégoire, D. L. MacLellan, G. A. Finley: A pediatric case of ketamine-associated cystitis (Letter-to-the-Editor RE: Shahani R, Streutker C, Dickson B, et al: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69: 810-812, 2007). In: Urology. Band 71, Nummer 6, Juni 2008, S. 1232–1233, doi:10.1016/j.urology.2007.11.141, PMID 18455768.
  • J. Yek, P. Sundaram, H. Aydin, T. Kuo, L. G. Ng: The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore. In: Singapore medical journal. Band 56, Nummer 12, Dezember 2015, S. 660–664, doi:10.11622/smedj.2015185, PMID 26702160, PMC 4678404 (freier Volltext).
  • C. H. Chen, M. H. Lee, Y. C. Chen, M. F. Lin: Ketamine-snorting associated cystitis. In: Journal of the Formosan Medical Association = Taiwan yi zhi. Band 110, Nummer 12, Dezember 2011, S. 787–791, doi:10.1016/j.jfma.2011.11.010, PMID 22248834 (Review).
  • S. Middela, I. Pearce: Ketamine-induced vesicopathy: a literature review. In: International journal of clinical practice Band 65, Nummer 1, Januar 2011, S. 27–30, doi:10.1111/j.1742-1241.2010.02502.x. PMID 21155941.
  • Chunmei Wang, Dong Zheng, Jie Xu, Waiping Lam, D. T. Yew: Brain damages in ketamine addicts as revealed by magnetic resonance imaging. In: Frontiers in Neuroanatomy. Band 7, 2013, doi:10.3389/fnana.2013.00023 (frontiersin.org [abgerufen am 30. August 2017]).

drugbank.ca

espacenet.com

worldwide.espacenet.com

europa.eu

echa.europa.eu

ema.europa.eu

ec.europa.eu

fda.gov

fda.gov

accessdata.fda.gov

feralhouse.com

frontiersin.org

journal.frontiersin.org

  • Chunmei Wang, Dong Zheng, Jie Xu, Waiping Lam, D. T. Yew: Brain damages in ketamine addicts as revealed by magnetic resonance imaging. In: Frontiers in Neuroanatomy. Band 7, 2013, doi:10.3389/fnana.2013.00023 (frontiersin.org [abgerufen am 30. August 2017]).

gov.uk

  • Advisory Council on the Misuse of Drugs (Großbritannien): Ketamine: a review of use and harm (PDF; 971 kB). Bericht für den Innenminister und den Gesundheitsminister, London, 10. Dezember 2013; abgerufen am 13. Oktober 2015.

nih.gov

ncbi.nlm.nih.gov

  • B. Sinner, B. M. Graf: Ketamine. In: Handbook of experimental pharmacology. Nummer 182, 2008, S. 313–333, doi:10.1007/978-3-540-74806-9_15, PMID 18175098 (Review).
  • SC Turfus, MC Parkin, DA Cowan, JM Halket, NW Smith, RA Braithwaite, SP Elliot, GB Steventon, AT Kicman: Use of human microsomes and deuterated substrates: an alternative approach for the identification of novel metabolites of ketamine by mass spectrometry. In: Drug Metab Dispos. Band 37, Nr. 8, 2009, S. 1769–78, doi:10.1124/dmd.108.026328, PMID 19448136, PMC 2712439 (freier Volltext) – (englisch).
  • E Kumlien, P Hartvig, S Valind, I Oye, J Tedroff, B Långström: NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. In: Epilepsia. Band 40, Nr. 1, 1999, S. 30–7, doi:10.1111/j.1528-1157.1999.tb01985.x, PMID 9924899 (englisch).
  • L Chen, Y Gong, R Salter: Synthesis of carbon-14 labeled ketamine and norketamine. In: J Labelled Comp Radiopharm. Band 61, Nr. 11, 2018, S. 864–868, doi:10.1002/jlcr.3669, PMID 29992626 (englisch).
  • L. V. Sayson, C. J. Botanas, R. J. P. Custodio et al.: The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors. In: Psychopharmacology (Berl). Band 236, Nr. 7, 2019, S. 2201–2210, doi:10.1007/s00213-019-05219-x, PMID 30891619 (englisch).
  • M. H. Y. Tang, T. C. Li, C. K. Lai, Y. K. Chong, C. K. Ching, T. W. L. Mak: Emergence of new psychoactive substance 2-fluorodeschloroketamine: Toxicology and urinary analysis in a cluster of patients exposed to ketamine and multiple analogues. In: Forensic Sci Int. Band 312, 2020, S. 110327, doi:10.1016/j.forsciint.2020.110327, PMID 32460225 (englisch).
  • Hirota K, Lambert DG: Ketamine: its mechanism(s) of action and unusual clinical uses. In: Br J Anaesth. Band 77, Nr. 4, 1996, S. 441–4, PMID 8942324 (englisch).
  • BA Orser, PS Pennefather, JF MacDonald: Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. In: Anesthesiology. Band 86, Nr. 4, 1997, S. 903–17, PMID 9105235 (englisch).
  • W Hevers, SH Hadley, H Lüddens, J Amin: Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits. In: J. Neurosci. Band 28, Nr. 20, 2008, S. 5383–5393, doi:10.1523/JNEUROSCI.5443-07.2008, PMID 18480294 (englisch).
  • SE Strasburger, PM Bhimani, JH Kaabe u. a.: What is the mechanism of Ketamine’s rapid-onset antidepressant effect? A concise overview of the surprisingly large number of possibilities. In: J Clin Pharm Ther. Band 42, Nr. 2, 2017, S. 147–154, doi:10.1111/jcpt.12497, PMID 28111761 (englisch).
  • Y Yang, Y Cui, K Sang, Y Dong, Z Ni, S Ma, H Hu: Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. In: Nature. Band 554, Nr. 7692, 2018, S. 317–322, doi:10.1038/nature25509, PMID 29446381 (englisch).
  • Artigas F, Celada P, Bortolozzi A: Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies. In: Eur Neuropsychopharmacol. Band 28, Nr. 4, April 2018, S. 457–482, doi:10.1016/j.euroneuro.2018.01.005, PMID 29525411 (englisch).
  • YQ Wan, JG Feng, M Li, MZ Wang, L Liu, X Liu, XX Duan, CX Zhang, XB Wang: Prefrontal cortex miR-29b-3p plays a key role in the antidepressant-like effect of ketamine in rats. In: Exp. Mol. Med. Band 50, Nr. 10, 2018, S. 140, doi:10.1038/s12276-018-0164-4, PMID 30369596, PMC 6204429 (freier Volltext) – (englisch).
  • S Chaki, JI Yamaguchi: Now is the time for (2R,6R)-hydroxynorketamine to be viewed independently from its parent drug. In: Pharmacol. Biochem. Behav. Band 175, 2018, S. 24–26, doi:10.1016/j.pbb.2018.09.005, PMID 30201385 (englisch).
  • JN Highland, PJ Morris, P Zanos u. a.: Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of ( 2R,6R)-hydroxynorketamine. In: J. Psychopharmacol. (Oxford). 2018, S. 269881118812095, doi:10.1177/0269881118812095, PMID 30488740 (englisch).
  • H.A. Adams, C. Werner: Vom Racemat zum Eutomer: (S)-Ketamin – Renaissance einer Substanz? In: Anaesthesist, Band 46, 1997, S. 1026–1042. PMID 9451486, doi:10.1007/s001010050503
  • J. A. Clements, W. S. Nimmo, I. S. Grant: Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. In: Journal of pharmaceutical sciences. Band 71, Nummer 5, Mai 1982, S. 539–542, PMID 7097501.
  • SM Burburan, DG Xisto, PR Rocco: Anaesthetic management in asthma. In: Minerva Anestesiol. Band 73, Nr. 6, Juni 2007, S. 357–365, PMID 17115010 (englisch).
  • KR Jat, D Chawla: Ketamine for management of acute exacerbations of asthma in children. In: Cochrane Database Syst Rev. Band 11, 2012, S. CD009293, doi:10.1002/14651858.CD009293.pub2, PMID 23152273 (englisch).
  • N. Diazgranados, L. Ibrahim, N. E. Brutsche, A. Newberg, P. Kronstein, S. Khalife, W. A. Kammerer, Z. Quezado, D. A. Luckenbaugh, G. Salvadore, R. Machado-Vieira, H. K. Manji, C. A. Zarate: A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. In: Archives of General Psychiatry. Band 67, Nummer 8, August 2010, S. 793–802, doi:10.1001/archgenpsychiatry.2010.90. PMID 20679587. PMC 3000408 (freier Volltext).
  • D. R. Lara, L. W. Bisol, L. R. Munari: Antidepressant, mood stabilizing and procognitive effects of very low dose sublingual ketamine in refractory unipolar and bipolar depression. In: The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum. Band 16, Nummer 9, Oktober 2013, S. 2111–2117, doi:10.1017/S1461145713000485, PMID 23683309.
  • A. C. Nugent, N. Diazgranados, P. J. Carlson, L. Ibrahim, D. A. Luckenbaugh, N. Brutsche, P. Herscovitch, W. C. Drevets, C. A. Zarate: Neural correlates of rapid antidepressant response to ketamine in bipolar disorder. In: Bipolar disorders. Band 16, Nummer 2, März 2014, S. 119–128, doi:10.1111/bdi.12118, PMID 24103187, PMC 3949142 (freier Volltext).
  • A. McGirr, M. T. Berlim, D. J. Bond, M. P. Fleck, L. N. Yatham, R. W. Lam: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes. In: Psychological medicine. Band 45, Nummer 4, März 2015, S. 693–704, doi:10.1017/S0033291714001603, PMID 25010396 (Review).
  • C. M. Coyle, K. R. Laws: The use of ketamine as an antidepressant: a systematic review and meta-analysis. In: Human psychopharmacology. Band 30, Nummer 3, Mai 2015, S. 152–163, doi:10.1002/hup.2475, PMID 25847818 (Review).
  • L. Reinstatler, N. A. Youssef: Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature. In: Drugs in R&D. Band 15, Nummer 1, März 2015, S. 37–43, doi:10.1007/s40268-015-0081-0, PMID 25773961, PMC 4359177 (freier Volltext) (Review).
  • M. C. Gregers, S. Mikkelsen, K. P. Lindvig, A. C. Brøchner: Ketamine as an Anesthetic for Patients with Acute Brain Injury: A Systematic Review. In: Neurocritical care. Band 33, Nummer 1, 08 2020, S. 273–282, doi:10.1007/s12028-020-00975-7, PMID 32328972, PMC 7223585 (freier Volltext).
  • M. Schönenberg, U. Reichwald, G. Domes, A. Badke, M. Hautzinger: Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims. In: Psychopharmacology. Band 182, Nummer 3, November 2005, S. 420–425, doi:10.1007/s00213-005-0094-4, PMID 16012867.
  • B. P. Lockhart, N. Tordo, H. Tsiang: Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. In: Antimicrobial agents and chemotherapy. Band 36, Nummer 8, August 1992, S. 1750–1755, PMID 1416859, PMC 192041 (freier Volltext).
  • K. L. Jansen, R. Darracot-Cankovic: The nonmedical use of ketamine, part two: A review of problem use and dependence. In: Journal of psychoactive drugs. Band 33, Nummer 2, 2001 Apr-Jun, S. 151–158, doi:10.1080/02791072.2001.10400480, PMID 11476262 (Review).
  • Jessica A. Albright, Sarah A. Stevens, Douglas J. Beussman: Detecting ketamine in beverage residues: Application in date rape detection. In: Drug Testing and Analysis. Vol. 4, No. 5, Mai 2012, S. 337–341, doi:10.1002/dta.335. PMID 22114065.
  • M. C. Grégoire, D. L. MacLellan, G. A. Finley: A pediatric case of ketamine-associated cystitis (Letter-to-the-Editor RE: Shahani R, Streutker C, Dickson B, et al: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69: 810-812, 2007). In: Urology. Band 71, Nummer 6, Juni 2008, S. 1232–1233, doi:10.1016/j.urology.2007.11.141, PMID 18455768.
  • J. Yek, P. Sundaram, H. Aydin, T. Kuo, L. G. Ng: The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore. In: Singapore medical journal. Band 56, Nummer 12, Dezember 2015, S. 660–664, doi:10.11622/smedj.2015185, PMID 26702160, PMC 4678404 (freier Volltext).
  • C. H. Chen, M. H. Lee, Y. C. Chen, M. F. Lin: Ketamine-snorting associated cystitis. In: Journal of the Formosan Medical Association = Taiwan yi zhi. Band 110, Nummer 12, Dezember 2011, S. 787–791, doi:10.1016/j.jfma.2011.11.010, PMID 22248834 (Review).
  • S. Middela, I. Pearce: Ketamine-induced vesicopathy: a literature review. In: International journal of clinical practice Band 65, Nummer 1, Januar 2011, S. 27–30, doi:10.1111/j.1742-1241.2010.02502.x. PMID 21155941.
  • S. S. Kalsi, D. M. Wood, P. I. Dargan: The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. In: Emerging health threats journal. Band 4, 2011, S. 7107, PMID 24149025, PMC 3168228 (freier Volltext) (Review).

pubchem.ncbi.nlm.nih.gov

pfizermed.de

sigmaaldrich.com

telegraph.co.uk

tumblr.com

tranxcend.tumblr.com

web.archive.org

welt.de

who.int

apps.who.int

  • World Health Organization (Hrsg.): WHO Model List of Essential Medicines. 18. Auflage. Oktober 2013, S. 1 [S. 5 im PDF] (englisch, who.int [PDF; abgerufen am 22. April 2014]).

wikidata.org